SciGen has recognised the huge potential of the Biopharmaceutical market, which is currently growing faster than any other market in the Healthcare industry. With a combination of shared wealth and increasing life expectancy of the world's population, the Biopharmaceutical market is expected to continue to grow much faster than other world markets, providing a strong foundation for SciGen's extensive biotechnological expertise and sound marketing infrastructure.
In view of the strong government support for the biotechnology sector, SciGen has adopted an approach to its product development which, in keeping with government initiatives, endeavours to supply competitively priced, state-of-the-art healthcare products to the greatest majority of the world's population.
SIE Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held